Skip to main content
PepStack
Wiki · Profile

Melanotan II

MT-2 · MT-II · Melanotan 2

Sexual HealthPhase II
From$1.38/mgCompare prices
MW
1024.2g/mol
Formula
C50H69N15O9

Melanotan II is a synthetic peptide classified as a non-selective melanocortin receptor agonist, derived from the natural hormone α-melanocyte-stimulating hormone (α-MSH). Researchers primarily study it for its effects on skin pigmentation and its potential role in sexual stimulation. Key findings indicate that Melanotan II can induce spontaneous penile erections and has been associated with adverse effects such as rhabdomyolysis and renal complications, including cases of renal infarction. Additionally, studies suggest that Melanotan II may influence appetite regulation by decreasing food consumption and motivation to eat when administered in specific brain regions. Current research continues to explore its pharmacological effects and safety profile, particularly in relation to its systemic toxicity and neurological impacts.

Chemical Profile

Chemical Profile

Chemical structure
Chemical Structure
FormulaC50H69N15O9
Molecular Weight1024.2 g/mol
CAS Number121062-08-6
PubChem CID92432
ChEMBL IDCHEMBL4297789

Half-Life

SCSubcutaneous

~1-2 hours

INIntranasal

Not applicable

POOral

Poor bioavailability

Subcutaneous administration is the most studied route, with limited data on other routes.

Mechanism

Mechanism of Action

Melanotan II is a non-selective agonist of melanocortin receptors, particularly MC3 and MC4, which activates signaling pathways involved in skin pigmentation (melanogenesis), appetite regulation, and sexual arousal. The activation of these receptors influences the proopiomelanocortin (POMC) pathway, leading to increased α-MSH production, which modulates feeding behavior and stimulates oxytocin neuronal activity in the hypothalamus. The precise molecular mechanisms underlying its systemic toxicity and effects on renal function remain incompletely understood.

Research

75 Research Publications

2,147

Total Citations

10

Human/RCT

1.9

Avg. Influence

2024

Latest

Sort
Filter
#01

Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study.

HumanInfluence3.0
161
Researchers observed that Melanotan II effectively initiated erections in 8 out of 10 men with psychogenic erectile dysfunction, with a mean duration of rigidity significantly longer than placebo.
0.01 mg/kgsubcutaneous(human)2 consecutive weeks0.005 mg/kgsubcutaneous(human)2 consecutive weeks0.03 mg/kgsubcutaneous(human)2 consecutive weeks0.025 mg/kgsubcutaneous(human)2 consecutive weeks60 nmol/kgintraperitoneal(rat)chronic treatment20 µg/kgsubcutaneous(rat)per 48 h3 mg/kgintraperitoneal(rat)not mentioned15 nmol/daycentral infusion(male Sprague-Dawley rats)7 days0.1 mg/kgintravenous(rat)not mentioned0.3 mg/kgintravenous(rat)not mentioned1 mg/kgintravenous(rat)not mentioned0.1 microgwithin the paraventricular nucleus of the hypothalamus(rat)not mentioned1 microgwithin the paraventricular nucleus of the hypothalamus(rat)not mentioned
PubMed
#02

Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.

HumanInfluence2.0
134
The study demonstrated that Melanotan II administration resulted in increased skin pigmentation and mild side effects in a pilot phase I clinical trial with human subjects.
6 mgsubcutaneous(human)not mentioned0.01 mg/kgsubcutaneous(human)2 consecutive weeks0.005 mg/kgsubcutaneous(human)not mentioned0.03 mg/kgsubcutaneous(human)not mentioned0.025 mg/kgsubcutaneous(human)not mentioned20 microg kg(-1) per 48 hsubcutaneous(rat)not mentioned0.1, 0.3 and 1 mg/kgintravenous(rat)not mentioned0.1 and 1 microgwithin the paraventricular nucleus of the hypothalamus(rat)not mentioned1 microgwithin the corpus cavernosum(rat)not mentioned
PubMed
#03

Differential Function of Melatonin MT

Gobbi Gabriella & Comai Stefano · Frontiers in endocrinology · 2019

ReviewInfluence2.0
132
Researchers reviewed the role of melatonin receptors in the body, focusing on their involvement in various physiological processes. They found that these receptors play a significant role in regulating sleep, mood, and other bodily functions. The study highlights the complexity of melatonin's effects through its different receptor types.

Key findings

  1. 01Researchers observed that melatonin receptors are crucial for regulating sleep patterns.
  2. 02The review highlighted the impact of these receptors on mood and emotional well-being.
  3. 03Researchers found that different types of melatonin receptors have distinct physiological roles.
PubMed
#04

Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.

HumanInfluence2.0
111
The study demonstrated that melanotan II effectively induces penile erection and increases sexual desire in men with erectile dysfunction, with significant side effects reported.
6 mgsubcutaneous(human)not mentioned0.01 mg/kgsubcutaneous(human)2 consecutive weeks0.005 mg/kgsubcutaneous(human)not mentioned0.03 mg/kgsubcutaneous(human)not mentioned0.025 mg/kgsubcutaneous(human)not mentioned20 microg kg(-1) per 48 hsubcutaneous(rat)not mentioned0.1, 0.3 and 1 mg/kgintravenous(rat)not mentioned0.1 and 1 microgwithin the paraventricular nucleus of the hypothalamus(rat)not mentioned1 microgwithin the corpus cavernosum(rat)not mentioned
PubMed
#05

Metallothionein in Brain Disorders.

Juárez-Rebollar Daniel, et al. · Oxidative medicine and cellular longevity · 2017

ReviewInfluence3.0
103
Researchers reviewed the role of metallothioneins, proteins that help manage essential metals in the brain, and their involvement in various brain disorders. They found that certain types of these proteins are linked to neurodegenerative diseases like Alzheimer's and Parkinson's, highlighting their importance in brain health.

Key findings

  1. 01Researchers observed that metallothioneins are crucial for maintaining metal balance in brain cells.
  2. 02The study found that metallothionein III is associated with the development of neurodegenerative diseases.
  3. 03Evidence suggests that metallothioneins may also play a role in other neurological disorders.
PubMed
#06

Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization.

ReviewInfluence2.0
94
The review highlighted the development of melanocortin peptide therapeutics, including melanotan II, for applications in tanning and erectile dysfunction, with ongoing clinical trials for new analogs.
6 mgsubcutaneous(human)not mentioned0.01 mg/kgsubcutaneous(human)2 consecutive weeks0.005 mg/kgsubcutaneous(human)not mentioned0.03 mg/kgsubcutaneous(human)not mentioned0.025 mg/kgsubcutaneous(human)not mentioned20 microg kg(-1) per 48 hsubcutaneous(rat)not mentioned0.1, 0.3 and 1 mg/kgintravenous(rat)not mentioned0.1 and 1 microgwithin the paraventricular nucleus of the hypothalamus(rat)not mentioned1 microgwithin the corpus cavernosum(rat)not mentioned
PubMed
#07

Agouti-related peptide and MC3/4 receptor agonists both inhibit excitatory hypothalamic ventromedial nucleus neurons.

AnimalInfluence2.0
84
Researchers observed that both melanotan-II and agouti-related peptide inhibited excitatory neurons in the hypothalamic ventromedial nucleus, suggesting additive inhibitory effects.
6 mgsubcutaneous(human)not mentioned0.01 mg/kgsubcutaneous(human)2 consecutive weeks0.005 mg/kg increments to 0.03 mg/kgsubcutaneous(human)2 consecutive weeks0.025 mg/kgsubcutaneous(human)not mentioned0.1, 0.3 and 1 mg/kgintravenous(rat)not mentioned1 mg/kgintravenous(rat)not mentioned20 microg kg(-1) per 48 hsubcutaneous(rat)not mentioned60 nmol/kg of body weight (BW)intraperitoneal(rat)not mentioned
PubMed
#08

Discovery that a melanocortin regulates sexual functions in male and female humans.

HumanInfluence2.0
79
Researchers observed that melanotan II enhanced sexual function in both male and female humans by acting at the brain level, resulting in increased erectile activity and sexual desire.
6 mgsubcutaneous(human)not mentioned0.01 mg/kgsubcutaneous(human)2 consecutive weeks0.005 mg/kgsubcutaneous(human)not mentioned0.03 mg/kgsubcutaneous(human)not mentioned0.025 mg/kgsubcutaneous(human)not mentioned20 microg kg(-1) per 48 hsubcutaneous(rat)not mentioned0.1, 0.3 and 1 mg/kgintravenous(rat)not mentioned0.1 and 1 microgwithin the paraventricular nucleus of the hypothalamus(rat)not mentioned1 microgwithin the corpus cavernosum(rat)not mentioned
PubMed
#09

Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery.

Animal
63
Researchers observed that nanostructured porous silicon microparticles enabled sustained delivery of Melanotan II, prolonging its physiological effects in vivo in mice.
6 mgsubcutaneous(human)not mentioned0.01 mg/kgsubcutaneous(human)2 consecutive weeks0.005 mg/kgsubcutaneous(human)not mentioned0.03 mg/kgsubcutaneous(human)not mentioned0.025 mg/kgsubcutaneous(human)not mentioned20 microg kg(-1) per 48 hsubcutaneous(rat)not mentioned0.1, 0.3 and 1 mg/kgintravenous(rat)not mentioned0.1 and 1 microgwithin the paraventricular nucleus of the hypothalamus(rat)not mentioned1 microgwithin the corpus cavernosum(rat)not mentioned
PubMed
#10

Orexin-A hyperphagia: hindbrain participation in consummatory feeding responses.

AnimalInfluence8.0
60
Researchers observed that melanotan II administration suppressed meal size in rats with hindbrain lesions, indicating its role in modulating consummatory feeding responses through the area postrema.
6 mgsubcutaneously(human)not mentioned0.01 mg/kgsubcutaneous(human)2 consecutive weeks0.005 mg/kg increments to 0.03 mg/kgsubcutaneous(human)2 consecutive weeks0.025 mg/kgnot mentioned(not mentioned)not mentioned20 microg kg(-1) per 48 hsubcutaneous(rat)not mentioned0.1, 0.3 and 1 mg/kgintravenous(rat)not mentioned0.1 and 1 microgwithin the paraventricular nucleus of the hypothalamus(rat)not mentioned
PubMed
Safety

Safety & Handling

Research Gaps

No comprehensive human clinical trials have been conducted to evaluate the long-term effects and safety profile of Melanotan II, particularly regarding its potential for systemic toxicity and renal complications. Additionally, the precise mechanisms by which Melanotan II influences oxytocin neuronal activity and its broader implications for social behaviors and neurological disorders remain unclear.

Solubility

Melanotan II is soluble in water and DMSO.

Storage & Handling

Lyophilized

Stable for 2+ years at -20°C, 12 months at 4°C

Reconstituted

Use within 14 days when refrigerated at 4°C

Avoid

Avoid repeated freeze-thaw cycles, direct light

Solvent

Bacteriostatic water or sterile saline recommended

Safety information is derived from published research and may not reflect all known risks. This is not medical advice.

Legal Status

Legal Status

🇩🇪DE

Not approved as a medicinal product. Not a controlled substance. Sale as research chemical is a legal grey area.

🇺🇸US

Not approved by the FDA as a drug. Not scheduled by the DEA.

🇦🇺AU

Not approved by the TGA. Considered a prescription-only medication.

🇬🇧UK

Not approved by the MHRA. Sale and distribution are restricted.

Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.

Community Insights

Community Insights

Publications per Year

49 total
2
94
1
96
1
00
1
02
2
03
1
04
1
05
3
06
3
07
2
08
1
11
2
12
1
13
1
14
2
15
1
17
3
18
1
19
8
20
3
21
3
22
1
23
5
24
Pricing

Price Comparison

  • BESTPeptiLab USAUS
    10mg
    $13.79
    Price/mg
    $1.38/mg
  • Alpha PeptidesUS
    10mg
    $22.79
    $20.51
    Price/mg
    $2.28$2.05/mg
    View10% · PEPSTACK10
  • Polaris PeptidesUS
    17mg
    $45.00
    Price/mg
    $2.65/mg
  • Ruo BioUS
    10mg
    $28.00
    Price/mg
    $2.80/mg
  • Puratek PeptidesUS
    10mg
    $27.95
    $25.16
    Price/mg
    $2.80$2.52/mg
    View10% · PEPSTACKS10

Top 5 of 39 offers from 41 vendors. Prices updated daily.

See all Melanotan II prices
Mechanism

Tools

Mechanism

Related Peptides

Track Melanotan II in PepStack

Log your research cycles, set reminders and visualize serum levels.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer